Cassaday & Co Wealth Management’s Champions Oncology CSBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50 Hold
10
– – ﹤0.01% 1241
2026
Q2
$62 Hold
10
– – ﹤0.01% 1292
2026
Q1
$58 Buy
+10
New +$64 ﹤0.01% 1346

Other funds holding CSBR

Cassaday & Co Wealth Management's CSBR Position: Q3 2026 in Review

Cassaday & Co Wealth Management held its Champions Oncology (CSBR) position steady in Q3 2026 at 10 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

Cassaday & Co Wealth Management first reported a position in CSBR in Q1 2026 and has held it in 3 quarters since. The position peaked at $62 in Q2 2026. 26 funds tracked by Wall St. Rank hold CSBR as of Q3 2026.

  • Cassaday & Co Wealth Management held 10 shares of Champions Oncology worth $50 as of Q3 2026.
  • Cassaday & Co Wealth Management left its Champions Oncology share count unchanged in Q3 2026.
  • Champions Oncology made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #1241 holding.
  • Cassaday & Co Wealth Management first reported a position in Champions Oncology in Q1 2026 and has held it in 3 quarters since.
  • Cassaday & Co Wealth Management's Champions Oncology position peaked at $62 in Q2 2026.
  • 26 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.